Toronto Dominion Bank’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12K Hold
75
﹤0.01% 2080
2026
Q1
$11K Sell
75
-300
-80% -$46K ﹤0.01% 1922
2025
Q4
$52K Hold
375
﹤0.01% 1664
2025
Q3
$47K Buy
375
+55
+17% +$6.71K ﹤0.01% 1618
2025
Q2
$39K Buy
320
+20
+7% +$2.25K ﹤0.01% 1523
2025
Q1
$33K Hold
300
﹤0.01% 1403
2024
Q4
$29K Hold
300
﹤0.01% 1418
2024
Q3
$34.5K Hold
300
﹤0.01% 1040
2024
Q2
$31.9K Sell
300
-2,270
-88% -$228K ﹤0.01% 1132
2024
Q1
$249K Hold
2,570
﹤0.01% 987
2023
Q4
$259K Hold
2,570
﹤0.01% 1110
2023
Q3
$248K Hold
2,570
﹤0.01% 1099
2023
Q2
$259K Sell
2,570
-790
-24% -$79K ﹤0.01% 1108
2023
Q1
$309K Sell
3,360
-240
-7% -$21K ﹤0.01% 1097
2022
Q4
$327K Buy
3,600
+180
+5% +$15.2K ﹤0.01% 1184
2022
Q3
$259K Hold
3,420
﹤0.01% 1274
2022
Q2
$290K Hold
3,420
﹤0.01% 1050
2022
Q1
$300K Buy
3,420
+1,320
+63% +$114K ﹤0.01% 1105
2021
Q4
$183K Sell
2,100
-1,646
-44% -$137K ﹤0.01% 1276
2021
Q3
$306K Sell
3,746
-10,718
-74% -$964K ﹤0.01% 1048
2021
Q2
$1.32M Sell
14,464
-5,304
-27% -$472K ﹤0.01% 832
2021
Q1
$1.69M Buy
19,768
+217
+1% +$19.5K ﹤0.01% 777
2020
Q4
$1.84M Sell
19,551
-276
-1% -$24.1K ﹤0.01% 803
2020
Q3
$1.73M Buy
19,827
+727
+4% +$63K ﹤0.01% 757
2020
Q2
$1.67M Sell
19,100
-131,953
-87% -$11.4M ﹤0.01% 751
2020
Q1
$12.5M Buy
151,053
+137,918
+1,050% +$12.3M 0.04% 301
2019
Q4
$1.24M Hold
13,135
﹤0.01% 849
2019
Q3
$1.14M Buy
13,135
+13,107
+46,811% +$1.18M ﹤0.01% 933
2019
Q2
$1K Sell
28
-15,119
-100% -$1.28M ﹤0.01% 1394
2019
Q1
$1.3M Sell
15,147
-2,489
-14% -$200K ﹤0.01% 932
2018
Q4
$1.36M Sell
17,636
-2,661
-13% -$207K ﹤0.01% 843
2018
Q3
$1.57M Buy
20,297
+3,715
+22% +$275K ﹤0.01% 818
2018
Q2
$1.12M Buy
16,582
+400
+2% +$27.6K ﹤0.01% 895
2018
Q1
$1.17M Sell
16,182
-603
-4% -$45.9K ﹤0.01% 808
2017
Q4
$1.26M Buy
16,785
+2,584
+18% +$195K ﹤0.01% 738
2017
Q3
$1.09M Buy
14,201
+2,755
+24% +$208K ﹤0.01% 685
2017
Q2
$857K Sell
11,446
-2,126
-16% -$151K ﹤0.01% 723
2017
Q1
$906K Sell
13,572
-3,353
-20% -$223K ﹤0.01% 718
2016
Q4
$1.11M Sell
16,925
-3,102
-15% -$201K ﹤0.01% 663
2016
Q3
$1.42M Buy
20,027
+1,805
+10% +$132K ﹤0.01% 359
2016
Q2
$1.35M Sell
18,222
-756
-4% -$52.2K 0.01% 282
2016
Q1
$1.23M Sell
18,978
-2,620
-12% -$178K 0.01% 254
2015
Q4
$1.67M Buy
21,598
+843
+4% +$67K 0.01% 274
2015
Q3
$1.72M Buy
20,755
+3,840
+23% +$342K 0.01% 256
2015
Q2
$1.49M Buy
16,915
+2,350
+16% +$216K 0.01% 328
2015
Q1
$1.29M Sell
14,565
-195
-1% -$17.3K 0.01% 329
2014
Q4
$1.22M Buy
14,760
+669
+5% +$55.5K ﹤0.01% 365
2014
Q3
$1M Sell
14,091
-311
-2% -$25.2K ﹤0.01% 363
2014
Q2
$1.17M Buy
14,402
+653
+5% +$51.4K ﹤0.01% 357
2014
Q1
$1.09M Buy
13,749
+5,952
+76% +$434K ﹤0.01% 348
2013
Q4
$561K Sell
7,797
-3,025
-28% -$210K ﹤0.01% 438
2013
Q3
$742K Sell
10,822
-549
-5% -$36.3K ﹤0.01% 345
2013
Q2
$723K Buy
+11,371
New +$740K ﹤0.01% 337

Other funds holding NVS

Toronto Dominion Bank's NVS Position: Q2 2026 in Review

Toronto Dominion Bank held its Novartis (NVS) position steady in Q2 2026 at 75 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #2080.

Toronto Dominion Bank first reported a position in NVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $12.5M in Q1 2020. 1,611 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Toronto Dominion Bank held 75 shares of Novartis worth $12K as of Q2 2026.
  • Toronto Dominion Bank left its Novartis share count unchanged in Q2 2026.
  • Novartis made up ﹤0.01% of Toronto Dominion Bank's portfolio in Q2 2026, its #2080 holding.
  • Toronto Dominion Bank first reported a position in Novartis in Q2 2013 and has held it in 53 quarters since.
  • Toronto Dominion Bank's Novartis position peaked at $12.5M in Q1 2020.
  • 1,611 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Toronto Dominion Bank's 13F filing for Q2 2026, filed 14 Aug 2026.